Tau has been associated with cognitive impairment later in the trajectory of Alzheimer’s disease (Pereira et al. 2021) and tauopathy has been suggested in relation to cognitive function in BD and has even been suggested as a novel therapeutic target (Naserkhaki et al. 2019). This evidence concerns the gene MAPT and tauopathy.